|
End-of-day quote
Shenzhen S.E.
19/10/2026
|
5-day change | 1st Jan Change | ||
| 8.040 CNY | +0.12% |
|
-4.17% | -6.94% |
| 09-10 | Lanzhou Foci Pharmaceutical Co.,Ltd. Approves 2026 Interim Profit Distribution Plan | CI |
| 08-20 | Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes 2026 Interim Profit Distribution Plan | CI |
| Market Cap | 4.11B 614M 545M 506M 460M 868M 58.23B 882M 6.08B 2.38B 30.39B 2.3B 2.25B 96.88B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.63B 542M 482M 447M 406M 767M 51.44B 779M 5.37B 2.1B 26.84B 2.03B 1.99B 85.57B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
33.12% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | +0.12% | ||
| 1 week | -4.17% | ||
| Current month | -2.66% | ||
| 1 month | -1.83% | ||
| 3 months | +2.94% | ||
| 6 months | -4.63% | ||
| Current year | -6.94% |
| 1 week | 7.89 | 8.3 | |
| 1 month | 7.89 | 8.53 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.02 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 06/04/2022 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 02/12/2022 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Guo Xian Bao
BRD | Director/Board Member | 71 | 12/05/2022 |
Xin Min Zhao
BRD | Director/Board Member | 56 | 02/01/2020 |
Wen Bo Su
CHM | Chairman | 60 | 08/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.12% | -4.17% | -10.17% | -20.79% | 613M | ||
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | ||
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | ||
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | ||
| -0.04% | +5.14% | +34.65% | +58.73% | 367B | ||
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | ||
| -0.14% | +3.70% | +19.45% | +46.78% | 288B | ||
| -0.80% | +2.54% | -1.85% | +17.58% | 258B | ||
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | ||
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | ||
| Average | -0.37% | +2.73% | +29.93% | +55.95% | 394.15B | |
| Weighted average by Cap. | -0.46% | +3.52% | +39.34% | +74.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 146M 130M 121M 110M 207M 13.9B 211M 1.45B 569M 7.26B 550M 538M 23.13B | 916M 137M 122M 113M 103M 194M 12.99B 197M 1.36B 531M 6.78B 514M 503M 21.6B |
| Net income | 60.07M 8.98M 7.98M 7.4M 6.73M 12.7M 852M 12.9M 88.91M 34.86M 445M 33.69M 32.98M 1.42B | 49.21M 7.35M 6.54M 6.06M 5.51M 10.4M 698M 10.57M 72.83M 28.55M 364M 27.6M 27.01M 1.16B |
| Net Debt | -357M -53.37M -47.44M -43.97M -40.01M -75.49M -5.07B -76.7M -529M -207M -2.64B -200M -196M -8.43B | -479M -71.59M -63.63M -58.98M -53.66M -101M -6.79B -103M -709M -278M -3.55B -269M -263M -11.3B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | CN¥8.040 | +0.12% | 4,487,200 |
| 16/10/26 | CN¥8.030 | -0.86% | 5,253,100 |
| 15/10/26 | CN¥8.100 | -0.61% | 4,039,600 |
| 14/10/26 | CN¥8.150 | -1.21% | 3,415,393 |
| 13/10/26 | CN¥8.250 | +1.60% | 5,634,088 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















